The primary focus of this document is to provide a consistent guidance for pharmaceutical companies to calculate GHG emissions in their upstream and downstream value chains. It provides methodologies consistent with recommendations from the GHG Protocol for calculating emissions which are tailored for each different category.

This document was developed by the Pharmaceutical Environment Group (PEG) and its participating companies, who have kindly shared it with the PSCI for diffusion.

This presentation on Indian Case Study on Controlling API Releases Including Wastewater Treatment/Analysis was delivered by:

• Jon Peers, Director of Environment, Teva

This session was facilitated by Annabel Buchan, Partner Manager at Carnstone.

The recording is available here. The slides are available for download below.

This introduction to sampling and analysing APIs in wastewater was delivered by:

• Jon Stanway, Biotechnology & Environmental Downstream Manager, GSK

This session was facilitated by Annabel Buchan, Partner Manager at Carnstone.

The recording is available here. The slides are available for download below.

This presentation on Draft Indian Wastewater Standards - Current Status and Possible Ramifications for Indian companies was delivered by:

• Mugundan Ramachandran, Senior Consultant, ERM India Private Limited
• Shivananda Shetty, Partner & Commercial Director, ERM India Private Limited

This session was facilitated by Annabel Buchan, Partner Manager at Carnstone.

The recording is available here. The slides are available for download below.

This presentation on Sustainable Packaging was delivered by:

• Jacqueline Hollands, Global Manager, Customer Sustainability Solutions, MilliporeSigma
• Victor Bell, US Managing Director, Lorax EPI
• Zelia Kranich, Sustainable Sourcing Associate Director, Merck & Co., and PSCI Environment Sub-Team Co-Lead

This session was facilitated by Annabel Buchan, Partner Manager at Carnstone.

The recording is available here. The slides are available for download below.

This presentation on Taking Climate Action was delivered by:

• Glynn Roberts, Director and Senior Partner, Carnstone

This session was facilitated by Annabel Buchan, Partner Manager at Carnstone.

The recording is available here. The slides are available for download below.

This PSCI Environment Sub-Team Overview was delivered by:

• Rikke Christensen, Head of Sustainable Procurement, LEO Pharma, and PSCI Environment Sub-Team Co-Lead
• Zelia Kranich, Sustainable Sourcing Associate Director, Merck & Co., and PSCI Environment Sub-Team Co-Lead

This session was facilitated by Annabel Buchan, Partner Manager at Carnstone.

The recording is available here. The slides are available for download below.

The second session of the 2020 PSCI India supplier conferences took place virtually on 24 September and covered Environment and Pharmaceuticals in the Environment/AMR.

The full recording of the session is available here. Slides are available for download below.

Recordings and slides of individual presentations are also available as individual resources - please click on the relevant links below:

• PSCI Environment Sub-Team Overview
• Taking climate action
• Sustainable Packaging
• The Global Problem of Pharmaceutical Pollution: to respect the decision of the speaker, the recording and slides are not shared here.
• Draft Indian Wastewater Standards - Current Status and Possible Ramifications for Indian companies
• Introduction to sampling and analysing APIs in wastewater
• Indian Case Study on Controlling API Releases

The webinar explored best practice wastewater treatment methods for managing the release of APIs into the environment from pharmaceutical manufacturing sites. It was delivered by renowned experts and featured case studies on novel treatment technologies.

We were delighted to be joined by the following speakers:

• Jeffrey Brenchley from Merck (MSD) (Senior Specialist, Global Safety & Environment), speaking about vacuum evaporation
• Birgit Mertens from Johnson & Johnson (Senior Principal Environment Worldwide EHS&S), speaking about ozone as pretreatment
• Jonathan Rhone from Axine Water Technologies Inc. (President and CEO), speaking about electrochemical oxidation

Participants are invited to share feedback about this webinar here.

The recording is available here. (Please refresh the page if you cannot play the video.)

The slides used during the webinar are available to download below.

Please also note that registration for the second session of our supplier conferences is open until 17 September. Topics covered will include climate change (GHG) & sustainable packaging ; sampling and analysing APIs in wastewater with case studies ; a case study on Controlling API Releases; environmental hazards of drugs and case analysis ; and mass balance calculations. To register, please click here for the China session and here for the India session.

Finally, we want your views! We're encouraging all suppliers to take this short survey to help the PSCI understand the impact it has on suppliers.

On behalf of the Board and Communications Committee and with thanks to the Pharmaceuticals in the Environment (PiE)/ Anti-Microbial Resistance (AMR) sub-team for their expert input, we are sharing the recently adopted PSCI Position Statement on PiE & AMR. It has been written to highlight the relevance of the PiE issue along the supply chain, to articulate PSCI's position on this high profile topic, and to help answer stakeholder inquiries. It includes an overview of all PSCI resources on PiE and AMR-related issues.

Presentation Pack from the 2018 PSCI Auditor Training, 4 - 5 December in Vienna, Austria

This is the slide deck from the PSCI sponsored webinar on how to manage APIs in manufacturing effluent (Part 4) which took place on 10th July 2018.

The webinar gave a brief refresher on Pharmaceuticals in the Environment (PiE), Anti-Microbial Resistance (AMR) and Predicted No-Effect Concentration (PNEC) first principles, and introduced a PSCI resource page where PNECs can be found. It also included step-by-step guidance on how to locate PNECs and use them.

The webinar recording is available here.

This is the slide deck for the PSCI sponsored webinar on how to manage APIs in manufacturing effluent (Part 3) which took place on 25th October 2016. The webinar looked at advanced technologies to reduce API loss with guest speakers from the Temple University WET Centre and AECOM.

This is the slide deck for the PSCI sponsored webinar on how to manage APIs in manufacturing effluent (Part 2) which took place on 15th June 2016. The webinar provided step-by-step guidance on this ‘spotlight’ issue for our industry and covered the following topics:

• estimating actual API losses from the manufacturing process (PEC)
• establishing the acceptable discharge concentration (PNEC)
• making low capital investment housekeeping steps to reduce the loss of APIs

The webinar recording is available here.

This is the slide deck for the PSCI sponsored webinar on how to manage APIs in manufacturing effluent which took place on 27th January 2016. The webinar provided step-by-step guidance on this ‘spotlight’ issue for our industry and covered the following topics:

• Why is managing active pharmaceutical ingredients (API) in manufacturing effluent important?
• What is the industry doing to improve public perceptions?
• Understanding where you stand at the moment through the maturity ladder concept.
• Establishing and calculating API discharge concentration called the Predicted-No-Effect-Concentration (PNEC).
• Simple steps to reducing API process losses to waste water and what to do when the PNEC is exceeded.
• How to advance your program to the next level.

The webinar recording is available here.

Abstract: This Caldwell et al. study describes guidance intended to assist pharmaceutical manufacturers in assessing, mitigating, and managing the potential environmental impacts of active pharmaceutical ingredients (APIs) in wastewater from manufacturing operations, including those from external suppliers.